In this study, the differences in the expression of METTL1 between carcinoma and paracancer cells of glioma were analyzed by bioinformatics, PCR, and immunohistochemistry experiments. METTL1 was knocked down in vitro for functional and pathway analysis. This evidence concerns the gene METTL1 and carcinoma.